Shelton Wealth Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,148
Closed -$1.31M 164
2026
Q1
$1.31M Buy
13,148
+1,263
+11% +$165K 0.57% 56
2025
Q4
$1.45M Buy
11,885
+1,449
+14% +$182K 0.62% 46
2025
Q3
$1.17M Buy
+10,436
New +$1.22M 0.53% 64

Other funds holding TMDX

Shelton Wealth Management's TMDX Position: Q2 2026 in Review

Shelton Wealth Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 13,148 shares — an estimated $1.31M sold.

Shelton Wealth Management first reported a position in TMDX in Q3 2025 and held it in 3 quarters. The position peaked at $1.45M in Q4 2025. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Shelton Wealth Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Shelton Wealth Management sold 13,148 Transmedics shares in Q2 2026, an estimated $1.31M.
  • Shelton Wealth Management first reported a position in Transmedics in Q3 2025 and held it in 3 quarters.
  • Shelton Wealth Management's Transmedics position peaked at $1.45M in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Shelton Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.